Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan
Background: Although tolvaptan, an electrolyte-free water diuretic for congestive heart failure (HF), is reported to have no effect on long-term mortality or HF-related morbidity, there may exist some subgroups of patients who may receive beneficial effect of tolvaptan. The purpose of this study was...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Therapeutic Advances in Cardiovascular Disease |
Online Access: | https://doi.org/10.1177/1753944718819064 |